Avsnitt (Re)programming Stem Cells for Drug Development Vital Science Spela Dela Facebook Twitter Kopiera länk
Mark Kotter, Founder and CEO of bit.bio, discusses technology to “reprogram” stem cells. Rss Apple Podcaster →